Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 09 - 19    source : Jaguarhealth.gcs-web.com    save search
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
Published: 2021-09-15 (Crawled : 00:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1611 -10.45% 14M twitter stocktwits trandingview |
Health Technology
 | | O: 2.13% H: 2.5% C: -1.25%
orphan drug europe test drug syndros crofelemer designation
Gainers vs Losers
84% 16%

Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M twitter stocktwits trandingview |

AGBA | $2.615 109.2% 14M twitter stocktwits trandingview |
Finance
EDBL | News | $7.37 96.01% 650K twitter stocktwits trandingview |

PALI | $7.64 54.97% 14M twitter stocktwits trandingview |
Manufacturing
OPRT | News | $3.19 41.78% 3M twitter stocktwits trandingview |
Finance
PEGY | $0.0629 37.34% 110M twitter stocktwits trandingview |
Manufacturing
MLEC | $1.87 33.57% 1.6M twitter stocktwits trandingview |
n/a
ATGL | $3.66 27.97% 150K twitter stocktwits trandingview |

VNRX | $0.759 26.5% 390K twitter stocktwits trandingview |
Health Technology
SMFL | $5.35 22.99% 11M twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.